chr17-50360095-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022167.4(XYLT2):c.2402C>T(p.Thr801Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T801R) has been classified as Benign.
Frequency
Consequence
NM_022167.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XYLT2 | NM_022167.4 | c.2402C>T | p.Thr801Ile | missense_variant | 11/11 | ENST00000017003.7 | NP_071450.2 | |
XYLT2 | XM_005257572.5 | c.2306C>T | p.Thr769Ile | missense_variant | 11/11 | XP_005257629.1 | ||
XYLT2 | XM_047436522.1 | c.1811C>T | p.Thr604Ile | missense_variant | 11/11 | XP_047292478.1 | ||
XYLT2 | NR_110010.2 | n.2221C>T | non_coding_transcript_exon_variant | 10/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XYLT2 | ENST00000017003.7 | c.2402C>T | p.Thr801Ile | missense_variant | 11/11 | 1 | NM_022167.4 | ENSP00000017003 | P1 | |
XYLT2 | ENST00000376550.7 | c.*286C>T | 3_prime_UTR_variant, NMD_transcript_variant | 10/10 | 1 | ENSP00000365733 | ||||
XYLT2 | ENST00000507602.5 | c.1941+2843C>T | intron_variant | 2 | ENSP00000426501 | |||||
XYLT2 | ENST00000571021.1 | n.1118C>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152052Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250440Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135474
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461580Hom.: 0 Cov.: 67 AF XY: 0.00000688 AC XY: 5AN XY: 727082
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152052Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74288
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 23, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt XYLT2 protein function. ClinVar contains an entry for this variant (Variation ID: 1985871). This variant has not been reported in the literature in individuals affected with XYLT2-related conditions. This variant is present in population databases (rs6504649, gnomAD 0.02%). This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 801 of the XYLT2 protein (p.Thr801Ile). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at